SMS Pharmaceuticals Ltd Q1FY23 consolidated loss at Rs. 12.76 crores

SMS Pharmaceuticals Limited has reported Consolidated financial results for the period ended June 30, 2022.

Financial Results (Q1 FY2023) - QoQ Comparison

The company has reported total income of Rs. 65.19 crores during the period ended June 30, 2022 as compared to Rs. 61.3454 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs. -12.7669 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs. 6.1741 crores for the period ended March 31, 2022.

The company has reported EPS of Rs. -1.51 for the period ended June 30, 2022 as compared to Rs. 0.73 for the period ended March 31, 2022.

Financials	Q1 FY2023	Q4 FY2022	% Change
Total Income	₹ 65.19 crs	₹61.3454 crs	6.27%
Net Profit	₹-12.7669 crs	₹6.1741 crs	-306.78%
EPS	₹-1.51	₹0.73	-306.85%

Financial Results (Q1 FY2023) - YoY Comparison

The company has reported total income of Rs. 65.19 crores during the period ended June 30, 2022 as compared to Rs.164.2873 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs.-12.7669 crores for the period ended June 30, 2022 as against net profit / (loss) of Rs.23.5627 crores for the period ended June 30, 2021.

The company has reported EPS of Rs.-1.51 for the period ended June 30, 2022 as compared to Rs.2.78 for the period ended June 30, 2021.

Financials	Q1 FY2023	Q1 FY2022	% Change
Total Income	₹ 65.19 crs	₹164.2873 crs	-60.32%
Net Profit	₹-12.7669 crs	₹23.5627 crs	-154.18%
EPS	₹-1.51	₹2.78	-154.32%

Shares of SMS Pharmaceuticals Limited was last trading in BSE at Rs. 86.50 as compared to the previous close of Rs. 86.50. The total number of shares traded during the day was 1307 in over 48 trades.

The stock hit an intraday high of Rs. 87.35 and intraday low of 84.00. The net turnover during the day was Rs. 112179.00.

Source : Equity Bulls

Keywords

SMSPharmaceuticals Q1FY23 ResultUpdate